Emergent BioSolutions (EBS) Misses Q2 EPS by 5c

August 1, 2019 5:06 PM EDT Send to a Friend

Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Emergent BioSolutions (EBS) Misses Q2 EPS by 5c

Member Login

Free News Feed